Companies / E-mirgency
E-mirgency
Saclay, France
E-mirgency is a cutting-edge technological startup that transforms cancer detection through miRNA technology
E-mirgency, based in Saclay, France, has 1 investor on file, among them Capital Cell. Its site was last checked 9 Nov 2026: site answers.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Investor |
More from Capital Cell
25 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (93%), Food & Agriculture (4%), Industrial & Manufacturing (4%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get E-mirgency and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Capital Cell adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/e-mirgency.com/investors
# also
GET /v1/companies/e-mirgency.com
GET /v1/companies/e-mirgency.com/news